Joanne Barnes

Summary

Affiliation: University of London
Country: UK

Publications

  1. ncbi Quality, efficacy and safety of complementary medicines: fashions, facts and the future. Part I. Regulation and quality
    Joanne Barnes
    Centre for Pharmacognosy and Phytotherapy, School of Pharmacy, University of London, London, UK
    Br J Clin Pharmacol 55:226-33. 2003
  2. ncbi Quality, efficacy and safety of complementary medicines: fashions, facts and the future. Part II: Efficacy and safety
    Joanne Barnes
    Centre for Pharmacognosy and Phytotherapy, School of Pharmacy, University of London, 29 39 Brunswick Square, London WC1N 1AX, UK
    Br J Clin Pharmacol 55:331-40. 2003
  3. ncbi Pharmacovigilance of herbal medicines : a UK perspective
    Joanne Barnes
    Centre for Pharmacognosy and Phytotherapy, School of Pharmacy, University of London, London, United Kingdom
    Drug Saf 26:829-51. 2003
  4. ncbi Echinacea species (Echinacea angustifolia (DC.) Hell., Echinacea pallida (Nutt.) Nutt.,Echinacea purpurea (L.) Moench): a review of their chemistry, pharmacology and clinical properties
    Joanne Barnes
    Centre for Pharmacognosy and Phytotherapy, School of Pharmacy, University of London, 29 39 Brunswick Square, London WC1N 1AX, UK
    J Pharm Pharmacol 57:929-54. 2005
  5. ncbi A pilot randomised, open, uncontrolled, clinical study of two dosages of St John's wort (Hypericum perforatum) herb extract (LI-160) as an aid to motivational/behavioural support in smoking cessation
    Joanne Barnes
    Centre for Pharmacognosy and Phytotherapy, School of Pharmacy, University of London, London, UK
    Planta Med 72:378-82. 2006
  6. ncbi Improving the quality of reporting of randomized controlled trials evaluating herbal interventions: implementing the CONSORT statement [corrected]
    Joel Gagnier
    Department of Health Policy, Management and Evaluation, Department of Medicine, Univerity of Toronto, Toronto, Canada
    Explore (NY) 2:143-9. 2006
  7. ncbi Recommendations for reporting randomized controlled trials of herbal interventions: Explanation and elaboration
    Joel J Gagnier
    Department of Health Policy, Management and Evaluation, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada
    J Clin Epidemiol 59:1134-49. 2006
  8. ncbi Reporting randomized, controlled trials of herbal interventions: an elaborated CONSORT statement
    Joel J Gagnier
    University of Toronto, Institute for Evaluative Sciences, Toronto, Canada
    Ann Intern Med 144:364-7. 2006
  9. ncbi Guidelines for submitting adverse event reports for publication
    William N Kelly
    William N Kelly Consulting, Inc, Oldsmar, Florida 34677, USA
    Drug Saf 30:367-73. 2007

Collaborators

Detail Information

Publications9

  1. ncbi Quality, efficacy and safety of complementary medicines: fashions, facts and the future. Part I. Regulation and quality
    Joanne Barnes
    Centre for Pharmacognosy and Phytotherapy, School of Pharmacy, University of London, London, UK
    Br J Clin Pharmacol 55:226-33. 2003
    ..A new system for registration of traditional herbal medicines will ensure that marketed products meet standards for quality and safety. At present, the pharmaceutical quality of many complementary medicines is a cause for concern...
  2. ncbi Quality, efficacy and safety of complementary medicines: fashions, facts and the future. Part II: Efficacy and safety
    Joanne Barnes
    Centre for Pharmacognosy and Phytotherapy, School of Pharmacy, University of London, 29 39 Brunswick Square, London WC1N 1AX, UK
    Br J Clin Pharmacol 55:331-40. 2003
    ..Data are lacking in several areas relevant to safety. Standard pharmacovigilance tools have additional limitations when applied to investigating safety concerns with complementary medicines...
  3. ncbi Pharmacovigilance of herbal medicines : a UK perspective
    Joanne Barnes
    Centre for Pharmacognosy and Phytotherapy, School of Pharmacy, University of London, London, United Kingdom
    Drug Saf 26:829-51. 2003
    ....
  4. ncbi Echinacea species (Echinacea angustifolia (DC.) Hell., Echinacea pallida (Nutt.) Nutt.,Echinacea purpurea (L.) Moench): a review of their chemistry, pharmacology and clinical properties
    Joanne Barnes
    Centre for Pharmacognosy and Phytotherapy, School of Pharmacy, University of London, 29 39 Brunswick Square, London WC1N 1AX, UK
    J Pharm Pharmacol 57:929-54. 2005
    ..Safety issues include the possibility of allergic reactions, the use of echinacea by patients with autoimmune diseases and the potential for echinacea preparations to interact with conventional medicines...
  5. ncbi A pilot randomised, open, uncontrolled, clinical study of two dosages of St John's wort (Hypericum perforatum) herb extract (LI-160) as an aid to motivational/behavioural support in smoking cessation
    Joanne Barnes
    Centre for Pharmacognosy and Phytotherapy, School of Pharmacy, University of London, London, UK
    Planta Med 72:378-82. 2006
    ..However, it may be premature to rule out a possible effect on the basis of a single, uncontrolled pilot study, and other approaches involving SJW extract may warrant investigation...
  6. ncbi Improving the quality of reporting of randomized controlled trials evaluating herbal interventions: implementing the CONSORT statement [corrected]
    Joel Gagnier
    Department of Health Policy, Management and Evaluation, Department of Medicine, Univerity of Toronto, Toronto, Canada
    Explore (NY) 2:143-9. 2006
    ..Given that herbal medicinal products are widely used, vary greatly in content and quality, and are actively tested in randomized controlled trials (RCTs), such RCTs must clearly report the specifics of the intervention...
  7. ncbi Recommendations for reporting randomized controlled trials of herbal interventions: Explanation and elaboration
    Joel J Gagnier
    Department of Health Policy, Management and Evaluation, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada
    J Clin Epidemiol 59:1134-49. 2006
    ..These recommendations for the reporting of herbal medicinal products presented here are open to revision as more evidence accumulates and critical comments are collected...
  8. ncbi Reporting randomized, controlled trials of herbal interventions: an elaborated CONSORT statement
    Joel J Gagnier
    University of Toronto, Institute for Evaluative Sciences, Toronto, Canada
    Ann Intern Med 144:364-7. 2006
    ..Item 4, concerning the herbal medicine intervention, required the most extensive elaboration. These recommendations have been developed to improve the reporting of RCTs using herbal medicine interventions...
  9. ncbi Guidelines for submitting adverse event reports for publication
    William N Kelly
    William N Kelly Consulting, Inc, Oldsmar, Florida 34677, USA
    Drug Saf 30:367-73. 2007
    ..They also encourage schools of medicine, pharmacy, and nursing to incorporate them into the relevant curricula that address the detection, evaluation, and reporting of suspected drug or other medical product adverse events...